Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9730910
Treatment of circadian rhythm disorders
granted -
US 9732359
Replication-competent adenoviral vectors
granted -
US 9730954
miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers
granted -
US 9730941
Methods and compositions for the inhibition of Pin1
granted -
US 9730962
Modalities for the treatment of degenerative diseases of the retina
granted -
US 9730993
Engineered anthrax lethal toxin for targeted delivery
granted -
US 9732095
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted -
US 9732337
RNA nanoparticles and nanotubes
granted -
US 9732333
Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
granted -
US 9732311
Alcoholic compositions having a lowered risk of acetaldehydemia
granted -
US 9732161
Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
granted -
US 9732114
Compounds having anti-adhesive effects on cancer cells
granted -
US 9732110
Nucleoside and nucleotide derivatives
granted -
US 9732124
Peptides and compositions for prevention of cell adhesion and methods of using same
granted -
US 9732189
Methods for preparing polymeric reagents and compositions of polymeric reagents
granted -
US 9732062
Therapeutically active compounds and their methods of use
granted -
US 9732080
Azaindole derivatives as CFTR modulators
granted -
US 9732070
Protein kinase C inhibitors and uses thereof
granted -
US 9732073
Compositions and methods for inhibition of the JAK pathway
granted -
US 9732067
Compounds and methods for activating the apoptotic arm of the unfolded protein response
granted -
US 9731011
Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma
granted -
US 9731002
HIV-1 GP 120 V1/V2 antigens and immunological uses thereof
granted -
US 9731023
Somatostatin receptor-based cancer therapy
granted -
US 9731009
Stable aqueous formulations of adalimumab
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.